Underuse of Anthracyclines in Women with HER-2(+) Advanced Breast Cancer

Anthracyclines are among the most active drugs in breast cancer. Because of excessive cardiotoxicity, their use in combination with trastuzumab has been discouraged in patients with human epidermal growth factor receptor (HER)-2(+) metastatic breast cancer. We sought to describe how this treatment p...

Descripción completa

Detalles Bibliográficos
Autores principales: Montemurro, Filippo, Rossi, Valentina, Nolè, Franco, Redana, Stefania, Donadio, Michela, Martinello, Rossella, Verri, Elena, Valabrega, Giorgio, Rocca, Maria Cossu, Jacomuzzi, Maria Elena, Viale, Giuseppe, Sapino, Anna, Aglietta, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2010
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228005/
https://www.ncbi.nlm.nih.gov/pubmed/20576644
http://dx.doi.org/10.1634/theoncologist.2010-0016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228005/
https://www.ncbi.nlm.nih.gov/pubmed/20576644
http://dx.doi.org/10.1634/theoncologist.2010-0016

Ejemplares similares